AAAAAA

   
Results: 1-15 |
Results: 15
APPLICATION OF AN ARTIFICIAL NEURAL-NETWORK TO PREDICT SPECIFIC CLASS-I MHC BINDING PEPTIDE SEQUENCES
Authors: MILIK M SAUER D BRUNMARK AP YUAN LL VITIELLO A JACKSON MR PETERSON PA SKOLNICK J GLASS CA
Citation: M. Milik et al., APPLICATION OF AN ARTIFICIAL NEURAL-NETWORK TO PREDICT SPECIFIC CLASS-I MHC BINDING PEPTIDE SEQUENCES, Nature biotechnology, 16(8), 1998, pp. 753-756
5-AMINOMETHYLQUINOXALINE-2,3-DIONES, PART-III - ARYLAMIDE DERIVATIVESAS HIGHLY POTENT AND SELECTIVE GLYCINE-SITE NMDA RECEPTOR ANTAGONISTS
Authors: ACKLIN P ALLGEIER H AUBERSON YP BISCHOFF S OFNER S SAUER D SCHMUTZ M
Citation: P. Acklin et al., 5-AMINOMETHYLQUINOXALINE-2,3-DIONES, PART-III - ARYLAMIDE DERIVATIVESAS HIGHLY POTENT AND SELECTIVE GLYCINE-SITE NMDA RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 8(5), 1998, pp. 493-498
TIME-COURSE OF MICROGLIA ACTIVATION AND APOPTOSIS IN VARIOUS BRAIN-REGIONS AFTER PERMANENT FOCAL CEREBRAL-ISCHEMIA IN MICE
Authors: RUPALLA K ALLEGRINI PR SAUER D WIESSNER C
Citation: K. Rupalla et al., TIME-COURSE OF MICROGLIA ACTIVATION AND APOPTOSIS IN VARIOUS BRAIN-REGIONS AFTER PERMANENT FOCAL CEREBRAL-ISCHEMIA IN MICE, Acta Neuropathologica, 96(2), 1998, pp. 172-178
EXPLORATION OF P-TYPE CA2+ CHANNELS AS DRUG TARGETS FOR THE TREATMENTOF EPILEPSY OR ISCHEMIC STROKE
Authors: LINGENHOHL K SMALL DL MONETTE R BUCHAN AM MORLEY P ALLEGRINI PR FROSTL W SAUER D SCHMUTZ M KNOPFEL T
Citation: K. Lingenhohl et al., EXPLORATION OF P-TYPE CA2+ CHANNELS AS DRUG TARGETS FOR THE TREATMENTOF EPILEPSY OR ISCHEMIC STROKE, Neuropharmacology, 36(1), 1997, pp. 107-113
ANGIOGRAPHIC EVOLUTION OF INTRACORONARY THROMBUS AND DISSECTION FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (THE THROMBOLYSIS AND ANGIOPLASTY IN UNSTABLE ANGINA [TAUSA] TRIAL)
Authors: AMBROSE JA ALMEIDA OD SHARMA SK DANGAS G RATNER DE TORRE SR MARMUR JD ISRAEL DH COHEN M LAFORGIA S WEISS MB HJEMDAHLMONSEN CE TREULIEB N MYLER RK SHAW R WARD K MOSES J WILENTZ J MANIKIAN A UNDEMIR C COHEN N UNTERECKER WJ OGILBY D HART B GRUNWALD AM KOSS J SAUER D GARRET JS LAGROTTERIA J COWLEY MJ DEBOTTIS D ANWAR A PETRARD G SOBOLSKI J BARKER WM TEOH N SWEENEY JM SCHUERR D FREDERICK L WALLENSTEIN S
Citation: Ja. Ambrose et al., ANGIOGRAPHIC EVOLUTION OF INTRACORONARY THROMBUS AND DISSECTION FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (THE THROMBOLYSIS AND ANGIOPLASTY IN UNSTABLE ANGINA [TAUSA] TRIAL), The American journal of cardiology, 79(5), 1997, pp. 559-563
REDUCTION OF EXCITOTOXICITY-INDUCED BRAIN-DAMAGE BY THE COMPETITIVE NMDA ANTAGONIST CGP-40116 - A LONGITUDINAL-STUDY USING DIFFUSION-WEIGHTED IMAGING
Authors: LAURENT D EIS M SAUER D THEILKAES W ALLEGRINI PR
Citation: D. Laurent et al., REDUCTION OF EXCITOTOXICITY-INDUCED BRAIN-DAMAGE BY THE COMPETITIVE NMDA ANTAGONIST CGP-40116 - A LONGITUDINAL-STUDY USING DIFFUSION-WEIGHTED IMAGING, Neuroscience letters, 213(3), 1996, pp. 209-212
AUTOIMMUNE HEMOLYTIC-ANEMIA FOLLOWING T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: DROBYSKI WR POTLURI J SAUER D GOTTSCHALL JL
Citation: Wr. Drobyski et al., AUTOIMMUNE HEMOLYTIC-ANEMIA FOLLOWING T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 17(6), 1996, pp. 1093-1099
THE COMPETITIVE NMDA ANTAGONIST CGP-40116 PERMANENTLY REDUCES BRAIN-DAMAGE AFTER MIDDLE CEREBRAL-ARTERY OCCLUSION IN RATS
Authors: SAUER D WEBER E LUOND G DASILVA F ALLEGRINI PR
Citation: D. Sauer et al., THE COMPETITIVE NMDA ANTAGONIST CGP-40116 PERMANENTLY REDUCES BRAIN-DAMAGE AFTER MIDDLE CEREBRAL-ARTERY OCCLUSION IN RATS, Journal of cerebral blood flow and metabolism, 15(4), 1995, pp. 602-610
RELATION BETWEEN MYOCARDIAL INFARCT LOCATION AND STROKE
Authors: BODENHEIMER MM SAUER D SHAREEF B BROWN MW FLEISS JL MOSS AJ
Citation: Mm. Bodenheimer et al., RELATION BETWEEN MYOCARDIAL INFARCT LOCATION AND STROKE, Journal of the American College of Cardiology, 24(1), 1994, pp. 61-66
THE COMPETITIVE NMDA RECEPTOR ANTAGONIST CGP-40116 IS A POTENT NEUROPROTECTANT IN A RAT MODEL OF FOCAL CEREBRAL-ISCHEMIA
Authors: SAUER D ALLEGRINI PR FAGG GE
Citation: D. Sauer et al., THE COMPETITIVE NMDA RECEPTOR ANTAGONIST CGP-40116 IS A POTENT NEUROPROTECTANT IN A RAT MODEL OF FOCAL CEREBRAL-ISCHEMIA, Journal of neural transmission. Supplementum, 1994, pp. 81-89
WORK LINKS - SYSTEMIC RATIONALIZATION OF INTERCOMPANY PRODUCTION PROCESSES
Authors: SAUER D DOHL V
Citation: D. Sauer et V. Dohl, WORK LINKS - SYSTEMIC RATIONALIZATION OF INTERCOMPANY PRODUCTION PROCESSES, Soziale Welt, 45(2), 1994, pp. 197-215
AUTOIMMUNE HEMOLYTIC-ANEMIA (AIHA) FOLLOWING T-CELL DEPLETED (TCD) ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: POTLURI J GOTTSCHALL J SAUER D DROBYSKI WR
Citation: J. Potluri et al., AUTOIMMUNE HEMOLYTIC-ANEMIA (AIHA) FOLLOWING T-CELL DEPLETED (TCD) ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 84(10), 1994, pp. 10000493-10000493
CHARACTERIZATION OF THE CEREBROPROTECTIVE EFFICACY OF THE COMPETITIVENMDA RECEPTOR ANTAGONIST CGP40116 IN A RAT MODEL OF FOCAL CEREBRAL-ISCHEMIA - AN IN-VIVO MAGNETIC-RESONANCE-IMAGING STUDY
Authors: SAUER D ALLEGRINI PR COSENTI A PATAKI A AMACKER H FAGG GE
Citation: D. Sauer et al., CHARACTERIZATION OF THE CEREBROPROTECTIVE EFFICACY OF THE COMPETITIVENMDA RECEPTOR ANTAGONIST CGP40116 IN A RAT MODEL OF FOCAL CEREBRAL-ISCHEMIA - AN IN-VIVO MAGNETIC-RESONANCE-IMAGING STUDY, Journal of cerebral blood flow and metabolism, 13(4), 1993, pp. 595-602
A NOTE ON THE COSTS TO GO PUBLIC INTERNATIONALLY
Authors: MOHAN N CHONG BS SAUER D
Citation: N. Mohan et al., A NOTE ON THE COSTS TO GO PUBLIC INTERNATIONALLY, Financial management, 22(1), 1993, pp. 17-17
RELATIONSHIP BETWEEN MYOCARDIAL INFARCT LOCATION AND STROKE
Authors: BODENHEIMER MM SAUER D SHAREEF B BROWN MW FLEISS JL MOSS AJ
Citation: Mm. Bodenheimer et al., RELATIONSHIP BETWEEN MYOCARDIAL INFARCT LOCATION AND STROKE, Circulation, 88(4), 1993, pp. 494-494
Risultati: 1-15 |